晚发型与成人型多发性硬化症的病理、临床及人口学特征比较
研究利用英国多发性硬化症登记处数据比较晚发型(≥50岁起病)与成人型(18-49岁起病)多发性硬化症的人口学和临床特征,并对独立队列进行病理学研究。结果显示晚发型女性比例更低、原发进展型比例更高、诊断时残疾程度更高、步态相关首发症状比例更高,且更少接受高效疾病修正治疗、更早达到显著残疾;病理上丘脑和脑桥神经元密度随起病年龄增长而降低,活动性脱髓鞘病灶和区室化炎症在成人型中最显著,仅神经元密度与晚发型残疾结局相关。
要点
- 晚发型多发性硬化症(起病≥50岁)女性比例更低、原发进展型比例更高。
- 晚发型诊断时残疾程度更高(中位MS影响量表36.7 vs 28.3,p<0.001),更少接受高效疾病修正治疗。
- 晚发型进展性病程与显著神经变性相关,而非频繁炎症性脱髓鞘。
核心结论
- 晚发型多发性硬化症的进展性更强与显著神经变性相关,但炎症性脱髓鞘不频繁。
研究设计与样本
- 利用英国多发性硬化症登记处数据比较晚发型(症状起病≥50岁)与成人型(起病18-49岁)的人口学和临床特征。
- 对另一多发性硬化症队列进行病理学研究,晚发型组18例(平均起病年龄54岁),成人型组23例(平均起病年龄29岁)。
主要发现
- 登记处队列中晚发型多发性硬化症有1,608例(9.4%)。
- 与成人型相比,晚发型女性比例更低、原发进展型比例更高、诊断时残疾程度更高(中位MS影响量表36.7 vs 28.3,p<0.001)、步态相关首发症状比例更高。
- 晚发型更少接受高效疾病修正治疗,并更早达到显著残疾。
- 控制死亡年龄和性别后,丘脑和脑桥神经元密度随起病年龄增长而降低,而活动性脱髓鞘病灶和区室化炎症在成人型中最显著。
- 在晚发型患者中,仅神经元密度与残疾结局相关,脱髓鞘或区室化炎症程度与残疾结局不相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Older people with multiple sclerosis (MS) have a less active radiological and clinical presentation, but many still attain significant levels of disability; but what drives worsening disability in this group? METHODS: We used data from the UK MS Register to characterize demographics and clinical features of late-onset multiple sclerosis (LOMS; symptom onset at ≥50 years), compared with adult-onset MS (AOMS; onset 18-49 years). We performed a pathology study of a separate MS cohort with a later onset (n = 18, mean age of onset 54 years) versus AOMS (n = 23, mean age of onset 29 years). RESULTS: In the Register cohort, there were 1,608 (9.4%) with LOMS. When compared with AOMS, there was a lower proportion of women, a higher proportion of primary progressive MS, a higher level of disability at diagnosis (median MS impact scale 36.7 vs. 28.3, p < 0.001), and a higher proportion of gait-related initial symptoms. People with LOMS were less likely to receive a high efficacy disease-modifying treatment and attained substantial disability sooner. Controlling for age of death and sex, neuron density in the thalamus and pons decreased with onset-age, whereas actively demyelinating lesions and compartmentalized inflammation was greatest in AOMS. Only neuron density, and not demyelination or the extent of compartmentalized inflammation, correlated with disability outcomes in older-onset MS patients. INTERPRETATION: The more progressive nature of older-onset MS is associated with significant neurodegeneration, but infrequent inflammatory demyelination. These findings have implications for the assessment and treatment of MS in older people. ANN NEUROL 2024;95:471-486.
引用
- Knowles S, Middleton R, Cooze B, et al. Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis. Ann Neurol. 2023. PMID: 38061895. doi:10.1002/ana.26843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。